NDC 25021-179 – Daptomycin

Daptomycin 350 mg/7mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC25021-179

Product details

Brand name
Daptomycin
Generic name
Daptomycin
Labeler
Sagent Pharmaceuticals
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
NDA · NDA208385
Marketed since
February 1, 2020
Listing expires
December 31, 2027
Pharmacologic class
Lipopeptide Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Daptomycin →

Package NDC codes (4)

Package NDCDescriptionSince
25021-179-151 VIAL in 1 CARTON (25021-179-15) / 7 mL in 1 VIALJan 15, 2018
25021-179-1610 VIAL in 1 CARTON (25021-179-16) / 7 mL in 1 VIALJan 15, 2018
25021-179-661 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIALFeb 1, 2020
25021-179-6710 VIAL in 1 CARTON (25021-179-67) / 7 mL in 1 VIALFeb 1, 2020

Other Daptomycin products